State of the art in lipoproteins: lessons from real life registries

28 August 2016 (14:00 - 14:18)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Borge Nordestgaard

Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail

Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012

Doctor S. Martin (Baltimore, US)

Abstract Slides Video

Presentation thumbnail

Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.

Mr G. Berkelmans (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study

Professor W. Koenig (Munich, DE)

Abstract Slides Video

Presentation thumbnail

Future direction for research in lipids.

Professor E. Bruckert (Paris, FR)

Access the full session

Session thumbnail

Lipoproteins and real life: what the randomized clinical trials do not show us

The Event

ESC Congress 2016

28 August 2016 14:00 CET

You may be interested in

Webinar

How to treat patients with borderline dyslipidemia

8 February 2023

Congress Presentation

Prognostic significance of elevated lipoprotein(a) in long-term outcomes after PCI with drug-eluting stents

31 August 2025

Congress Presentation

Welcome & introduction

29 August 2025

Webinar

LDL-C reduction postACS: strike early and strike strong

15 November 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources